Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...